October 8, 2025

Cost Assessment of Pediatric Haploidentical Hematopoietic Stem Cell Transplantation.

View Full Paper

Ask AI

Bookmark

Authors

Discussion

Cost assessment compares pediatric haplo-SCT and geno-SCT, revealing higher expenses in pediatric patients, indicating new reimbursement needs.

Higher expenses for pediatric patients are linked to the intensive conditioning regimens used before haplo-SCT.
Pediatric haplo-SCT incurred more costs compared to geno-SCT, impacting financial planning for health coverage.
Complications during neutropenia and after HSCT, like GVHD and CMV reactivation, significantly increase treatment costs.
The study aims to establish reimbursement packages tailored for the cost structures in pediatric haplo-SCT and geno-SCT.

Achour et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Cost assessment compares pediatric haplo-SCT and geno-SCT, revealing higher expenses in pediatric patients, indicating new reimbursement needs.